Squarepoint Ops LLC lessened its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 6.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 924,237 shares of the company's stock after selling 68,116 shares during the quarter. Squarepoint Ops LLC owned about 0.48% of ChampionX worth $25,130,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of CHX. Barclays PLC grew its holdings in ChampionX by 147.2% during the 3rd quarter. Barclays PLC now owns 357,081 shares of the company's stock valued at $10,766,000 after buying an additional 212,654 shares during the last quarter. Park Avenue Securities LLC lifted its stake in shares of ChampionX by 7.6% during the 4th quarter. Park Avenue Securities LLC now owns 28,846 shares of the company's stock worth $784,000 after purchasing an additional 2,031 shares during the period. Nisa Investment Advisors LLC boosted its holdings in shares of ChampionX by 899.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 211,103 shares of the company's stock worth $5,740,000 after purchasing an additional 189,977 shares during the last quarter. KBC Group NV boosted its holdings in shares of ChampionX by 42.3% during the fourth quarter. KBC Group NV now owns 8,289 shares of the company's stock worth $225,000 after purchasing an additional 2,462 shares during the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in shares of ChampionX by 1.9% during the fourth quarter. Pacer Advisors Inc. now owns 28,394 shares of the company's stock worth $772,000 after purchasing an additional 532 shares during the last quarter. Institutional investors and hedge funds own 98.99% of the company's stock.
Analysts Set New Price Targets
Separately, Stifel Nicolaus raised their price objective on ChampionX from $39.00 to $40.00 and gave the stock a "buy" rating in a report on Monday, May 5th.
View Our Latest Stock Analysis on CHX
ChampionX Trading Down 0.1%
Shares of CHX stock traded down $0.02 during mid-day trading on Friday, hitting $24.48. 3,558,468 shares of the company's stock were exchanged, compared to its average volume of 2,705,427. ChampionX Co. has a fifty-two week low of $21.92 and a fifty-two week high of $35.94. The stock has a 50-day simple moving average of $25.97 and a two-hundred day simple moving average of $28.07. The company has a quick ratio of 1.36, a current ratio of 1.99 and a debt-to-equity ratio of 0.32. The stock has a market cap of $4.69 billion, a price-to-earnings ratio of 14.84 and a beta of 1.52.
ChampionX (NASDAQ:CHX - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.09. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. The business had revenue of $864.46 million for the quarter, compared to analysts' expectations of $900.59 million. During the same quarter last year, the firm earned $0.50 earnings per share. The business's revenue was down 6.3% on a year-over-year basis. Equities analysts expect that ChampionX Co. will post 1.92 EPS for the current fiscal year.
ChampionX Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 3rd will be issued a $0.095 dividend. This represents a $0.38 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Thursday, July 3rd. ChampionX's payout ratio is currently 25.17%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Read More

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.